stockrow
Friday 6 November 2026
Export BIOA’s income statement to Excel — free account
BioAge Labs, Inc.
BIOA Healthcare Drug Manufacturers Specialty & Generic
BioAge Labs, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million.
- Revenue
- −85.5%
- EPS
- −30.4%
- Free cash flow
- −92.8%
- Total debt
- −83.6%
Quarter to September 2026, against a year earlier
5.30
0.24
−4.33%
Follow BIOA
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (34.56%) | (28.21%) | (25.98%) | (27.09%) |
+8 more TTM periods Free account |
|
| (32.05%) | (26.27%) | (24.26%) | (24.68%) | ||
ROIC |
(21.75%) | (118.25%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(38.89%) | (30.25%) | (23.84%) | (30.12%) | |
Average Days of Receivables |
23.98 | 22.03 | 25.09 | 31.20 | |
Free Cash Flow per Share |
(5.61) | (5.42) | (5.73) | (6.60) | |
Free Cash Flow |
(257.75) | (242.84) | (243.38) | (237.09) | |
Capital Expenditures |
(155.23) | (155.23) | (155.07) | (155.47) | |
| Other line items | |||||
Cash ROIC |
(74.40%) | (35.01%) | (31.88%) | (42.66%) | |
Accounts Receivable Turnover |
15.92 | 16.86 | 19.28 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,157.20% | 847.78% | 807.16% | 822.30% | |
Selling, General and Administrative Expense of Revenue |
344.61% | 278.49% | 278.77% | 309.16% | |
Share Based Compensation of Revenue |
184.80% | 135.57% | 126.00% | 129.97% | |
Interest Coverage |
— | (378.19) | (211.45) | (133.11) | |
Operating CF/Net income |
0.95 | 0.93 | 0.98 | 1.01 | |
Depreciation/Fixed assets |
0.25 | 0.21 | 0.21 | 0.22 | |
Capex/Depreciation |
(550.46) | (618.47) | (648.81) | (729.89) | |
Revenue per Share |
0.19 | 0.23 | 0.24 | 0.25 | |
Operating CF per Share |
(2.23) | (1.95) | (2.08) | (2.27) | |
Capex per Share |
(3.38) | (3.46) | (3.65) | (4.33) | |
Capex to Sales |
18.05 | 14.99 | 15.03 | 17.28 |
Columns are period end dates · fundamentals updated 5 Nov 2026